請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/28337
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 林琬琬(Wan-Wan Lin) | |
dc.contributor.author | Tsai-Yu Chen | en |
dc.contributor.author | 陳摘宇 | zh_TW |
dc.date.accessioned | 2021-06-13T00:05:30Z | - |
dc.date.available | 2010-08-08 | |
dc.date.copyright | 2007-08-08 | |
dc.date.issued | 2007 | |
dc.date.submitted | 2007-07-28 | |
dc.identifier.citation | Abreu-Martin, M.T., Vidrich, A., Lynch, D.H., and Targan, S.R. (1995). Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-alpha and ligation of Fas antigen. J Immunol 155, 4147-4154.
Ahn, J.H., Park, S.M., Cho, H.S., Lee, M.S., Yoon, J.B., Vilcek, J., and Lee, T.H. (2001). Non-apoptotic signaling pathways activated by soluble Fas ligand in serum-starved human fibroblasts. Mitogen-activated protein kinases and NF-kappaB-dependent gene expression. J Biol Chem 276, 47100-47106. Alderson, M.R., Armitage, R.J., Maraskovsky, E., Tough, T.W., Roux, E., Schooley, K., Ramsdell, F., and Lynch, D.H. (1993). Fas transduces activation signals in normal human T lymphocytes. J Exp Med 178, 2231-2235. Alnemri, E.S., Livingston, D.J., Nicholson, D.W., Salvesen, G., Thornberry, N.A., Wong, W.W., and Yuan, J. (1996). Human ICE/CED-3 protease nomenclature. Cell 87, 171. Barnhart, B.C., Alappat, E.C., and Peter, M.E. (2003). The CD95 type I/type II model. Semin Immunol 15, 185-193. Bubici, C., Papa, S., Dean, K., and Franzoso, G. (2006). Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance. Oncogene 25, 6731-6748. Budihardjo, I., Oliver, H., Lutter, M., Luo, X., and Wang, X. (1999). Biochemical athways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 15, 269-290. Bursch, W. (2001). The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ 8, 569-581. Bursch, W., Ellinger, A., Gerner, C., Frohwein, U., and Schulte-Hermann, R. (2000). Programmed cell death (PCD). Apoptosis, autophagic PCD, or others? Ann NY Acad Sci 926, 1-12. Chan, F.K., Shisler, J., Bixby, J.G., Felices, M., Zheng, L., Appel, M., Orenstein, J., Moss, B., and Lenardo, M.J. (2003). A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses. J Biol Chem 278, 51613-51621. Choi, C., and Benveniste, E.N. (2004). Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses. Brain Res 44, 65-81. Ciechanover, A. (2006). Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. Exp Bio Med 231, 1197-1211. Curtin, J.F., Donovan, M., and Cotter, T.G. (2002). Regulation and measurement of oxidative stress in apoptosis. J Immunol Methods 265, 49-72. Denecker, G., Vercammen, D., Declercq, W., and Vandenabeele, P. (2001). Apoptotic and necrotic cell death induced by death domain receptors. Cell Mol Life Sci 58, 356-370. Devin, A., Cook, A., Lin, Y., Rodriguez, Y., Kelliher, M., and Liu, Z. (2000). The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity 12, 419-429. Dosreis, G.A., Borges, V.M., and Zin, W.A. (2004). The central role of Fas-ligand cell signaling in inflammatory lung diseases. J Cell Mol Med 8, 285-293. Edinger, A.L., and Thompson, C.B. (2004). Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Bio 16, 663-669. Fiers, W., Beyaert, R., Declercq, W., and Vandenabeele, P. (1999). More than one way to die: apoptosis, necrosis and reactive oxygen damage. Oncogene 18, 7719-7730. Gerschenson, L.E., and Rotello, R.J. (1992). Apoptosis: a different type of cell death. FASEB J 6, 2450-2455. Ghobrial, I.M., Witzig, T.E., and Adjei, A.A. (2005). Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin 55, 178-194. Gloire, G., Legrand-Poels, S., and Piette, J. (2006). NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol 72, 1493-1505. Griffith, T.S., Brunner, T., Fletcher, S.M., Green, D.R., and Ferguson, T.A. (1995). Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270, 1189-1192. Holler, N., Zaru, R., Micheau, O., Thome, M., Attinger, A., Valitutti, S., Bodmer, J.L., Schneider, P., Seed, B., and Tschopp, J. (2000). Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 1, 489-495. Hsu, H., Huang, J., Shu, H.B., Baichwal, V., and Goeddel, D.V. (1996). TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4, 387-396. Huang, J., Wu, L., Tashiro, S., Onodera, S., and Ikejima, T. (2005). The augmentation of TNFalpha-induced cell death in murine L929 fibrosarcoma by the pan-caspase inhibitor Z-VAD-fmk through pre-mitochondrial and MAPK-dependent pathways. Acta Med Okayama 59, 253-260. Hyer, M. L., Samuel, T., and Reed, J. C. (2006). The FLIP-side of Fas signaling. Clin Cancer Res 12, 5292-5231 Imamura, R., Konaka, K., Matsumoto, N., Hasegawa, M., Fukui, M., Mukaida, N., Kinoshita, T., and Suda, T. (2004). Fas ligand induces cell-autonomous NF-kappaB activation and interleukin-8 production by a mechanism distinct from that of tumor necrosis factor-alpha. J Biol Chem 279, 46415-46423. Jin, Z., and El-Deiry, W.S. (2005). Overview of cell death signaling pathways. Cancer Biol Ther 4, 139-163. Kam, P.C., and See, A.U. (2000). Cyclo-oxygenase isoenzymes: physiological and pharmacological role. Anaesthesia 55, 442-449. Kamata, H., Honda, S., Maeda, S., Chang, L., Hirata, H., and Karin, M. (2005). Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120, 649-661. Kataoka, T., Budd, R.C., Holler, N., Thome, M., Martinon, F., Irmler, M., Burns, K., Hahne, M., Kennedy, N., Kovacsovics, M, Tschopp, J. (2000). The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. Curr Biol 10, 640-648. Kelliher, M.A., Grimm, S., Ishida, Y., Kuo, F., Stanger, B.Z., and Leder, P. (1998). The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity 8, 297-303. Khwaja, A., and Tatton, L. (1999). Resistance to the cytotoxic effects of tumor necrosis factor alpha can be overcome by inhibition of a FADD/caspase-dependent signaling pathway. J Biol Chem 274, 36817-36823. Klionsky, D.J., and Emr, S.D. (2000). Autophagy as a regulated pathway of cellular degradation. Science 290, 1717-1721. Kondo, T., Suda, T., Fukuyama, H., Adachi, M., and Nagata, S. (1997). Essential roles of the Fas ligand in the development of hepatitis. Nat Med 3, 409-413. Kreuz, S., Siegmund, D., Rumpf, J.J., Samel, D., Leverkus, M., Janssen, O., Hacker, G., Dittrich-Breiholz, O., Kracht, M., Scheurich, P., Wajant, H. (2004). NFkappaB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP. J Cell Biol 166, 369-380. Kuwano, K., Hagimoto, N., Kawasaki, M., Yatomi, T., Nakamura, N., Nagata, S., Suda, T., Kunitake, R., Maeyama, T., Miyazaki, H., Hara, N. (1999). Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. J Clin Invest 104, 13-19. Kyriakis, J.M., and Avruch, J. (2001). Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81, 807-869. Lamkanfi, M., Declercq, W., Vanden Berghe, T., and Vandenabeele, P. (2006). Caspases leave the beaten track: caspase-mediated activation of NF-kappaB. J Cell Biol 173, 165-171. Lee, S.H., Soyoola, E., Chanmugam, P., Hart, S., Sun, W., Zhong, H., Liou, S., Simmons, D., and Hwang, D. (1992). Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem 267, 25934-25938. Levine, B., and Yuan, J. (2005). Autophagy in cell death: an innocent convict? J Clin Invest 115, 2679-2688. Li, M., and Beg, A.A. (2000). Induction of necrotic-like cell death by tumor necrosis factor alpha and caspase inhibitors: novel mechanism for killing virus-infected cells. J Virol 74, 7470-7477. Lin, Y., Devin, A., Rodriguez, Y., and Liu, Z.G. (1999). Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Gene Dev 13, 2514-2526. Lin, Y., Choksi, S., Shen, H.M., Yang, Q.F., Hur, G.M., Kim, Y.S., Tran, J.H., Nedospasov, S.A., and Liu, Z.G. (2004). Tumor necrosis factor-induced nonapoptotic cell death requires receptor-interacting protein-mediated cellular reactive oxygen species accumulation. J Biol Chem 279, 10822-10828. Liu, C.Y., Takemasa, A., Liles, W.C., Goodman, R.B., Jonas, M., Rosen, H., Chi, E., Winn, R.K., Harlan, J.M., and Chuang, P.I. (2003). Broad-spectrum caspase inhibition paradoxically augments cell death in TNF-alpha -stimulated neutrophils. Blood 101, 295-304. Livolsi, A., Busuttil, V., Imbert, V., Abraham, R.T., and Peyron, J.F. (2001). Tyrosine phosphorylation-dependent activation of NF-kappa B. Requirement for p56 LCK and ZAP-70 protein tyrosine kinases. Eur J Biochem 268, 1508-1515. Longthorne, V.L., and Williams, G.T. (1997). Caspase activity is required for commitment to Fas-mediated apoptosis. EMBO J 16, 3805-3812. MacFarlane, M., and Williams, A.C. (2004). Apoptosis and disease: a life or death decision. EMBO Rep 5, 674-678. Malhi, H., Gores, G.J., and Lemasters, J.J. (2006). Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology 43, S31-44. Martinez-Vicente, M., Sovak, G., and Cuervo, A.M. (2005). Protein degradation and aging. Exp Gerontol 40, 622-633. Matsuzawa, A., and Ichijo, H. (2005). Stress-responsive protein kinases in redox-regulated apoptosis signaling. Antioxid Redox Signal 7, 472-481. May, M.J., and Madge, L.A. (2007). Caspase inhibition sensitizes inhibitor of NF-kappaB kinase beta-deficient fibroblasts to caspase-independent cell death via the generation of reactive oxygen species. J Biol Chem 282, 16105-16116. Meylan, E., and Tschopp, J. (2005). The RIP kinases: crucial integrators of cellular stress. Trends Biochem Sci 30, 151-159. Mitsiades, C. S., Poulaki, V., Fanourakis, G., Sozopoulos, E., McMillin, D., Wen, Z., Voutsinas, G., Tseleni-Balafouta, S., and Mitsiades, N. (2006). Fas signaling in thyroid carcinomas is diverted from apoptosis to proliferation. Clin Cancer Res 12, 3705-3712. Nagata, S. (1999). Fas ligand-induced apoptosis. Ann Rev Genet 33, 29-55. Nicotera, P., Leist, M., and Manzo, L. (1999). Neuronal cell death: a demise with different shapes. Trends Pharmacol Sci 20, 46-51. Nunez, G., Benedict, M.A., Hu, Y., and Inohara, N. (1998). Caspases: the proteases of the apoptotic pathway. Oncogene 17, 3237-3245. Orrenius, S., Gogvadze, V., and Zhivotovsky, B. (2007). Mitochondrial oxidative stress: implications for cell death. Ann Rev Pharmacol 47, 143-183. Ott, M., Gogvadze, V., Orrenius, S., and Zhivotovsky, B. (2007). Mitochondria, oxidative stress and cell death. Apoptosis 12, 913-922. Palao, G., Santiago, B., Galindo, M. A., Rullas, J. N., Alcami, J., Ramirez, J. C., and Pablos, J. L. (2006). Fas activation of a proinflammatory program in rheumatoid synoviocytes and its regulation by FLIP and caspase 8 signaling. Arthritis Rheum 54, 1473-1481. Park, S. M., Schickel, R., and Peter, M. E. (2005). Nonapoptotic functions of FADD-binding death receptors and their signaling molecules. Curr Opin Cell Bio 17, 610-616 Perfettini, J.L., and Kroemer, G. (2003). Caspase activation is not death. Nat Immunol 4, 308-310. Rubinsztein, D.C. (2006). The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 443, 780-786. Sakon, S., Xue, X., Takekawa, M., Sasazuki, T., Okazaki, T., Kojima, Y., Piao, J.H., Yagita, H., Okumura, K., Doi, T., Nakano, H. (2003). NF-kappaB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. EMBO J 22, 3898-3909. Schaub, F.J., Han, D.K., Liles, W.C., Adams, L.D., Coats, S.A., Ramachandran, R.K., Seifert, R.A., Schwartz, S.M., and Bowen-Pope, D.F. (2000). Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells. Nat Med 6, 790-796. Scheller, C., Knoferle, J., Ullrich, A., Prottengeier, J., Racek, T., Sopper, S., Jassoy, C., Rethwilm, A., and Koutsilieri, E. (2006). Caspase inhibition in apoptotic T cells triggers necrotic cell death depending on the cell type and the proapoptotic stimulus. J Cell Biochem 97, 1350-1361. Scheller, C., Sopper, S., Ehrhardt, C., Flory, E., Chen, P., Koutsilieri, E., Ludwig, S., ter Meulen, V., and Jassoy, C. (2002). Caspase inhibitors induce a switch from apoptotic to proinflammatory signaling in CD95-stimulated T lymphocytes. Eur J Immunol 32, 2471-2480. Schoonbroodt, S., Ferreira, V., Best-Belpomme, M., Boelaert, J.R., Legrand-Poels, S., Korner, M., and Piette, J. (2000). Crucial role of the amino-terminal tyrosine residue 42 and the carboxyl-terminal PEST domain of IkappaB alpha in NF-kappa B activation by an oxidative stress. J Immunol 164, 4292-4300. Schrauwen, P., and Hesselink, M.K. (2004). Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. Diabetes 53, 1412-1417. Schwartz, L.M., Smith, S.W., Jones, M.E., and Osborne, B.A. (1993). Do all programmed cell deaths occur via apoptosis? Proc Natl Acad of Sci USA 90, 980-984. Shi, Y. (2002). Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 9, 459-470. Slee, E.A., Zhu, H., Chow, S.C., MacFarlane, M., Nicholson, D.W., and Cohen, G.M. (1996). Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem J 315, 21-24. Storz, P., and Toker, A. (2003). Protein kinase D mediates a stress-induced NF-kappaB activation and survival pathway. EMBO J 22, 109-120. Swanson, M.S. (2006). Autophagy: eating for good health. J Immunol 177, 4945-4951. Takada, Y., Mukhopadhyay, A., Kundu, G.C., Mahabeleshwar, G.H., Singh, S., and Aggarwal, B.B. (2003). Hydrogen peroxide activates NF-kappa B through tyrosine phosphorylation of IkappaB alpha and serine phosphorylation of p65: evidence for the involvement of IkappaB alpha kinase and Syk protein-tyrosine kinase. J Biol Chem 278, 24233-24241. Tavernarakis, N. (2007). Cardiomyocyte necrosis: alternative mechanisms, effective interventions. Biochim Biophys Acta 1773, 480-482. Tewari, M., Telford, W.G., Miller, R.A., and Dixit, V.M. (1995). CrmA, a poxvirus-encoded serpin, inhibits cytotoxic T-lymphocyte-mediated apoptosis. J Biol Chem 270, 22705-22708. Tsujimoto, Y., and Shimizu, S. (2005). Another way to die: autophagic programmed cell death. Cell Death Differ 12 Suppl 2, 1528-1534. Vandenabeele, P., Vanden Berghe, T., and Festjens, N. (2006). Caspase inhibitors promote alternative cell death pathways. Sci STKE 358, pe44 Ventura, J.J., Cogswell, P., Flavell, R.A., Baldwin, A.S., Jr., and Davis, R.J. (2004). JNK potentiates TNF-stimulated necrosis by increasing the production of cytotoxic reactive oxygen species. Gene Dev 18, 2905-2915. Vercammen, D., Beyaert, R., Denecker, G., Goossens, V., Van Loo, G., Declercq, W., Grooten, J., Fiers, W., and Vandenabeele, P. (1998a). Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med 187, 1477-1485. Vercammen, D., Brouckaert, G., Denecker, G., Van de Craen, M., Declercq, W., Fiers, W., and Vandenabeele, P. (1998b). Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J Exp Med 188, 919-930. Vermeulen, K., Van Bockstaele, D.R., and Berneman, Z.N. (2005). Apoptosis: mechanisms and relevance in cancer. Ann Hematol 84, 627-639. Wajant, H., Pfizenmaier, K., and Scheurich, P. (2003). Non-apoptotic Fas signaling. Cytokine Growth Factor Rev 14, 53-66. Wilson, C.A., and Browning, J.L. (2002). Death of HT29 adenocarcinoma cells induced by TNF family receptor activation is caspase-independent and displays features of both apoptosis and necrosis. Cell Death Differ 9, 1321-1333. Wong, B., Arron, J., and Choi, Y. (1997). T cell receptor signals enhance susceptibility to Fas-mediated apoptosis. J Exp Med 186, 1939-1944. Xu, Y., Kim, S.O., Li, Y., and Han, J. (2006a). Autophagy contributes to caspase-independent macrophage cell death. J Biol Chem 281, 19179-19187. Xu, Y., Huang, S., Liu, Z.G., and Han, J. (2006b). Poly(ADP-ribose) polymerase-1 signaling to mitochondria in necrotic cell death requires RIP1/TRAF2-mediated JNK1 activation. J Biol Chem 281, 8788-8795. Yeh, W.C., Shahinian, A., Speiser, D., Kraunus, J., Billia, F., Wakeham, A., de la Pompa, J.L., Ferrick, D., Hum, B., Iscove, N., Ohashi, P., Rothe, M., Goeddel, D. V., Mak, T. W. (1997). Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7, 715-725. Yu, L., Alva, A., Su, H., Dutt, P., Freundt, E., Welsh, S., Baehrecke, E.H., and Lenardo, M. (2004). Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 304, 1500-1502. Yu, L., Wan, F., Dutta, S., Welsh, S., Liu, Z., Freundt, E., Baehrecke, E.H., and Lenardo, M. (2006). Autophagic programmed cell death by selective catalase degradation. Proc Natl Acad Sci USA 103, 4952-4957. Yuan, J., Shaham, S., Ledoux, S., Ellis, H.M., and Horvitz, H.R. (1993). The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 75, 641-652. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/28337 | - |
dc.description.abstract | Fas是死亡受體的原型,當它活化的時候可以直接活化凋亡蛋白酵素,最終導致各種細胞凋亡的產生。Fas所傳達的細胞凋亡分子機轉已經被研究得非常透徹;但是,除了引發細胞凋亡之外,最近的研究顯示:在細胞凋亡的路徑被抑制的時候,Fas也可以引起一些非細胞凋亡的訊息傳遞路徑。目前,Fas所傳導的這種替代性訊息傳遞路徑的分子機轉仍然不甚清楚。在本研究當中,我們利用小鼠胚胎纖維母細胞來探討Fas所傳達的凋亡蛋白酵素非依賴型細胞死亡的訊息傳遞路徑,以及這種傳遞路徑和發炎反應之間的相關性。我們發現,在小鼠胚胎纖維母細胞中,Fas ligand所引起的細胞死亡會因為前處理廣效型凋亡蛋白酵素抑制劑z-VAD-FMK後而更為增強。我們的結果顯示RIP和TRAF2在這種凋亡蛋白酵素非依賴型細胞死亡中扮演了很重要的角色。這種凋亡蛋白酵素非依賴型的細胞死亡也和細胞內活性氧化物(ROS)的累積相關,而活性氧化物的清除劑butylated hydroxyanisol (BHA)則可以預防這種的細胞死亡。此外,我們還觀察到延遲且持續的JNK和NF-kB的活化,及粒腺體膜電位損壞,這些現象也都可以利用前處理BHA而消失。我們也發現在前處理z-VAD-FMK後, FasL除了會引起凋亡蛋白酵素非依賴型的細胞死亡,同時也可以引起強烈的發炎反應,包括造成COX-2以及IL-8表現量增加,而這個發炎反應是和持續的JNK以及NF-kB的活化有關。總結來說,我們闡述Fas ligand在小鼠胚胎纖維母細胞所誘發的非依賴凋亡蛋白酵素的訊息傳遞路徑,會導致細胞的死亡和發炎反應的發生。 | zh_TW |
dc.description.abstract | Fas is the prototype of the death receptors which can directly activate caspases and eventually lead to apoptosis in various cell types. The molecular mechanism of Fas-mediated apoptosis has been well investigated. However, besides apoptosis, recent studies showed that Fas can induce some non-apoptotic signaling pathways under conditions where apoptosis pathways have been inhibited. Nowadays, the molecular mechanism of these alternative signaling pathways mediated by Fas remains unclear. In this study, we investigated the signaling pathway of Fas-mediated caspase-independent cell death and the coupling of this alternative cell death to inflammatory responses in mouse embryonic fibroblasts (MEFs). We found that in MEFs, FasL induced cell death was sensitized under pre-treatment of pan-caspase inhibitor z-VAD-FMK. Our results revealed that RIP and TRAF2 may play important roles in FasL-induced caspase-independent cell death. This death is also associated with intracellular reactive oxygen species (ROS) accumulation, as the ROS scavenger butylated hydroxyanisol (BHA) can prevent the cell death. Furthermore, delayed and sustained JNK, NF-kB activation, and mitochondrial membrane potential breakdown were observed. These phenomena can be eliminated by pre-treatment of BHA. We also found that in company with caspase-independent cell death, Fas ligand can also induce strong inflammatory responses including COX-2 and IL-8 gene up-regulation. This inflammatory response is associated with the delayed and sustained JNK and NF-kB activation. Taken together, we demonstrate caspase-independent signaling pathway of Fas in MEF, and show its activation lead to cell death and inflammatory responses. | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T00:05:30Z (GMT). No. of bitstreams: 1 ntu-96-R94443006-1.pdf: 2460029 bytes, checksum: ee23c42dafc4e96a9dc601a794126c50 (MD5) Previous issue date: 2007 | en |
dc.description.tableofcontents | Abbreviations...................................................................................................................1
Abstract............................................................................................................................3 Abstract in Chinese........................................................................................................5 Introduction......................................................................................................................6 Research aims of this study...........................................................................................22 Materials and Methods.................................................................................................23 Results.............................................................................................................................32 Discussion.......................................................................................................................48 Figures............................................................................................................................58 References.........................................................................................................................81 AppendixⅠ.......................................................................................................................95 AppendixⅡ.......................................................................................................................96 | |
dc.language.iso | en | |
dc.title | 探討Fas Ligand經由非依賴型凋亡蛋白酵素所誘發之細胞死亡以及發炎反應的訊息傳遞路徑 | zh_TW |
dc.title | Signaling pathways of FasL-induced caspase-independent cell death and inflammatory responses | en |
dc.type | Thesis | |
dc.date.schoolyear | 95-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 顏茂雄(Mao-Hsiung Yen),朱清良(Ching-Liang Chu),楊春茂(Chuen-Mao Yang),蘇銘嘉(Ming-Jai Su) | |
dc.subject.keyword | 凋亡蛋白酵素,活性氧化物,細胞死亡,發炎反應, | zh_TW |
dc.subject.keyword | Fas ligand,caspase-independent cell death,ROS,inflammatory responses, | en |
dc.relation.page | 96 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2007-07-30 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 藥理學研究所 | zh_TW |
顯示於系所單位: | 藥理學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-96-1.pdf 目前未授權公開取用 | 2.4 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。